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Abstract
Endocarditis caused by Abiotrophia and Granulicatella species, formerly known as nutri-
tionally variant streptococci (NVS) is rare. It is associated with increased complications 
such as heart failure, systemic emboli, valve replacement surgery, treatment failures 
and mortality. The diagnosis of these infections is challenging due to specific nutri-
tional growth requirements although modern techniques such as 16S rRNA sequence 
analysis and Matrix-assisted laser desorption ionization time-of-flight mass spectrom-
etry (MALDI-TOF MS) are particularly useful. Penicillin resistance among these organ-
isms is a growing problem. Penicillin and gentamicin combination or alternatively 
Vancomycin alone are the recommended treatment options, however there is increasing 
data regarding susceptibilities to other antibiotics. Varying susceptibilities to antibiotics 
among different species of NVS needs to be studied further.
Keywords: Abiotrophia and Granulicatella endocarditis, aorto-right ventricular fistula, 
Abiotrophia endocarditis
1. Introduction
Nutritionally variant (deficient) streptococci (NVS) were first described by Frankel and Hirsch 
in 1961 [1]. These gram positive bacteria resembled streptococci but had specific nutritional 
growth requirements. Since their first identification, over the years nomenclature of NVS 
changed several times based on DNA-DNA hybridization studies and 16S rRNA sequence 
analysis. They were first included in the genus Streptococcus, then genus Abiotrophia, and finally 
they were recognized as two separate genera; genus Abiotrophia and genus Granulicatella. Genus 
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Abiotrophia consists of Abiotrophia defectiva and genus Granulicatella consists of Granulicatella 
adiacens, Granulicatella elegans, Granulicatella balaenopterae and Granulicatella para-adiacens.
NVS are members of the normal flora of human pharynx, human urogenital and intestinal 
tracts [2].
Infective endocarditis caused by NVS is rare, causing approximately 2% of all cases of infective 
endocarditis [3]. Over 125 cases of infective endocarditis caused by Abiotrophia and Granulicatella 
spp. have been reported to date. It is estimated that approximately 5–6% of all cases of strepto-
coccal endocarditis are caused by NVS [4]. Due to the fastidious nature of these organisms and 
difficulties in diagnosis, it is possible that endocarditis caused by NVS may be under-recognized. 
NVS are among the organisms causing culture negative endocarditis. The main reservoir of 
infective endocarditis inducing NVS is oral cavity as in the case of other viridans streptococci [5].
Although endocarditis and bacteremia are the most common infections associated by 
Abiotrophia and Granulicatella spp., the literature for infections caused by Abiotrophia and 
Granulicatella spp. has been growing with new sites of infections being reported as our aware-
ness of these bacteria heightens and our diagnostic capabilities improve.
Ophthalmological infections have been encountered, ranging from keratitis to endophthalmi-
tis [6]. NVS are known to cause corneal ulcers [7], vitreous infections [8] and infectious crys-
talline keratopathy [9]. Orthopedic infections, including prosthesis infection, septic arthritis, 
discitis and sacroiliitis have been reported [10–12]. Synovial biopsy sample from a patient 
with culture negative endocarditis also yielded NVS [13]. NVS are also associated with cen-
tral nervous system infections; more commonly brain abscesses but rarely meningitis [14], 
subarachnoid hemorrhage [15] and intracranial aneurysms [3] have been reported. CNS infec-
tions have been commonly linked to embolic phenomena, neurosurgical instrumentation and 
immunosuppression [10, 16]. NVS have been isolated from patients with otitis media [1], otitis 
externa [2], sinusitis [17], parapneumonic effusion [18], cirrhosis [19], peritonitis [20], pan-
creatic abscess [21], bacteremia associated with postpartum or postabortal sepsis [19], tubo-
ovarian abscess [22], breast implant associated infection [23], wound infections, and vaginal 
discharge [24]. Endarteritis caused by A. defectiva involving the main pulmonary artery in a 
patient with asymptomatic patent ductus arteriosus has been reported [25].
2. Microbiology
Nutritionally variant streptococci were first described by Frenkel and Hirsch in 1961 from blood 
cultures of cases of subacute bacterial endocarditis and from otitis media. These cell wall deficient, 
L form ‘streptococci’ were noted to grow in satellite colonies around other bacteria requiring sub-
stances secreted by other bacteria for growth [1]. ‘Abiotrophia’ means life nutrition deficiency, 
referring to the need of specific nutrients in media for growth of these bacteria [26]. They are cata-
lase-negative, oxidase-negative, facultative anaerobic gram positive bacteria [27]. They often form 
white-gray, non-hemolytic colonies. These organisms hardly grow in culture media that strepto-
cocci ordinarily grow, such as sheep blood agar. They require supplementation of L-cysteine or 
pyridoxal HCl. In the absence of these supplements, NVS can also grow forming satellite colonies 
adjacent to streaks of helper bacteria such as Staphylococcus aureus or Staphylococcus epidermidis.
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Bouvet et al. in 1989 showed that NVS could be divided into two groups, Streptococcus defecti-
vus and Streptococcus adiacens by DNA–DNA hybridization studies. They noted that there was 
less than 10% DNA homology with the reference streptococcus species [28].
In 1995, Kawamura et al. proposed that these distinct species be transferred to a new genus, 
Abiotrophia, as Abiotrophia adiacens and Abiotrophia defectiva by using 16S rRNA gene sequenc-
ing. Subsequently two new species were added to this genus; Abiotrophia elegans [29] iso-
lated from a patient with endocarditis and Abiotrophia balaenopterae [30] from a minke whale 
(Balaenoptera acutorostrata).
Finally, in 2000, Collins et al. proposed the taxonomy of NVS that we use today. They pointed 
out that genus Abiotrophia consisted of two distinct lines. Abiotrophia defectiva and a robust 
group consisting of A. adiacens, A. balaenopterae and A. elegans. They reclassified A. adiacens, 
A. balaenopterae and A. elegans into genus Granulicatella (small chain of small grains in Latin) 
and Abiotrophia defectiva into genus Abiotrophia [27]. Shortly before this taxonomy revision, 
Kanamoto et al. proposed a new strain, Abiotrophia para-adiacens, related to Granulicatella adia-
cens which is rarely reported but not widely published [31, 32].
3. Pathophysiology
Bacterial attachment to damaged heart valves is the key factor in infective endocarditis. Intact 
vascular endothelium can resist the development of endocarditis [33]. Experimental animal 
models showed that when catheter induced endocardial damage is produced; these endo-
cardial lesions can be infected by direct inoculation of bacteria or by intravenous inocula-
tion [34]. Pathophysiology of infective endocarditis typically would start with endothelial 
cell denudation, followed by exposure of underlying extracellular matrix (ECM) and finally 
binding of fibrin and platelets [33]. Extracellular matrix proteins are exposed during damage 
to the cardiac endothelium providing potential sites of attachment for virulent organisms [35] 
Granulicatella and Abiotrophia spp. have the ability to bind to fibronectin and other extracel-
lular matrix proteins. The ability to bind to extracellular matrix proteins appears to correlate 
with the degree of infectivity of NVS [5].
Some groups of NVS are more pathogenic and other groups are less pathogenic. Highly 
pathogenic G. adiacens has high fibronectin binding ability. Highly pathogenic A. defectiva 
strains also have strong ability to bind to fibronectin and other ECM proteins whereas less 
pathogenic G. para-adiacens and G. elegans strains show low ability to bind to fibronectin and 
all other ECM proteins [5]. Similarly, among non-NVS streptococci that are commonly associ-
ated with infective endocarditis, S. mutans, S. mitis, S. sanguis and S. fecalis also have the ability 
to bind to the extracellular matrix [35].
By binding to the extracellular matrix proteins, bacteria are able to adhere to the dam-
aged endocardium and subsequently producing colonization and infection. ECM binding 
ability however is not the sole indicator of pathogenicity. Some strains of NVS have high 
infectivity without significant binding to the ECM proteins suggesting other mechanisms 
involved in pathogenesis. Other mechanisms of endocardial infectivity of NVS remains to 
be discovered [5].
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As a group, NVS have heterogenous properties of pathogenicity. A. defectiva has higher patho-
genicity compared to other species of NVS [5]. About 73% of all NVS isolates from patients 
with bacterial endocarditis are Abiotrophia defectiva. G. para-adiacens and G. elegans strains are 
less virulent than A. defectiva and G. adiacens [5].
Okada et al. noted that [5] NVS isolates from endocarditis patients and from normal oral flora 
both had the ability to cause infective endocarditis.
4. Diagnosis
Identification of Abiotrophia and Granulicatella spp. in blood cultures is extremely difficult. 
NVS do not grow well in subcultures and may be regarded as contaminant bacteria. Their 
extreme pleomorphism may lead to misidentification of these bacteria as other bacteria, even 
fungi [36, 37]. Christensen and Facklam [38] studied 101 NVS isolates and reported that iso-
lates were gram variable and pleomorphic, forms varied from bacilli with spore like swellings 
to cocci predominantly in pairs and chains when gram stain preparations were made from 
agar plates. NVS can demonstrate bulbous swelling and filament formation and they can 
form rough colony morphology on chocolate agar that can be suggestive of other microorgan-
isms such as Streptobacillus moniliformis or Erysipelothrix rhusiopathiae [36].
NVS show morphologic variations depending on the pyridoxal concentrations in the growth 
medium [39]. Due to the difficulties in identification of these bacteria, it is crucial for micro-
biology staff to be vigilant and be aware of the pleomorphic nature of the NVS to prevent 
misidentification.
NVS should be suspected when gram stain shows microbial cells but cultures are negative [2]. 
Once their nutritional growth requirements are supplemented in media, NVS convert to 
streptococci-like cells [39] and gram positivity making them easier to identify, although it 
was also shown that correcting nutritional deficiency may not convert all abnormalities [40]. 
For G. elegans, addition of cysteine to growth media would have the effect of reversal of pleo-
morphic morphology but addition of pyridoxal HCl does not [29]. The difficulty in identify-
ing these organisms leads to delays in diagnosis and thus timely initiation of appropriate 
antimicrobial treatment [41].
Contemporary blood culture methods enable Abiotrophia and Granulicatella spp. to grow rou-
tinely, visible colonies of these organisms appear in 48 h on subculture from positive blood 
culture media supplemented with Brucella and chocolate subculture media [3].
Cargill et al. noted that anaerobic blood culture bottles became positive sooner than aerobic 
blood cultures bottles; (3.56 h, standard deviation 8.49 h) although they noted that this was 
not significant or reliable [31].
Specific phenotypic characteristics of NVS can be identified by examining their patterns of 
production of α-galactosidase, β-galactosidase, β-glucosidase, N-acetyl-β-glucosaminidase 
and β-glucuronidase, and fermentation of trehalose, pullulan, tagatose and sucrose [32, 38].
A. defectiva produces α-galactosidase, β-galactosidase and produces acid from trehalose, 
sucrose and pullulan. Its acid production from tagatose is variable [38].
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G. adiacens produces β-glucuronidase and produces acid from sucrose and tagatose. G. elegans 
hydrolyses arginine. Its hippurate hydrolysis is variable. It produces acid from sucrose. 
G. balaenopterae hydrolyses arginine and produces acid from trehalose and pullulan. [38]
G. para-adiacens produces β-glucosidase, does not produce α- or β-galactosidase or arginine 
and does not ferment trehalose, pullulan or tagatose [32].
Molecular diagnostic techniques can be used for rapid and accurate diagnosis of NVS in blood 
or tissue samples. PCR amplification of 16S rRNA and restriction fragment length polymor-
phism (RFLP) for routine detection of NVS was developed by Ohara-Nemoto et al. in 1997 
[42]. For culture negative infective endocarditis, molecular techniques appear to be more sen-
sitive in resected valvular tissue compared to blood samples [43].
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF 
MS) is a fast, reliable and cost-effective technique used to identify microorganisms by utiliz-
ing MALDI-TOF MS devices in the clinical microbiology labs [44]. These devices carry the 
potential to complement or replace the phenotypic identification of various microorganisms 
including bacteria [44]. MALDI-TOF MS is a rapid and accurate diagnostic tool that has been 
used to identify and timely diagnose NVS [45].
In culture negative endocarditis, Abiotrophia and Granulicatella spp. should be suspected and 
supplemented media should be performed for the organisms to grow. Once the growth is 
achieved, PCR amplification of 16S rRNA or MALDI-TOF mass spectrometry can be utilized 
for rapid and accurate diagnosis [46].
5. Clinical presentation and complications
Endocarditis caused by NVS typically follows a slow and indolent course. Endocarditis devel-
ops as a result of bacteremia. Abiotrophia and Granulicatella spp. are causes of endocarditis 
with severe complications such as congestive heart failure, valvular destruction, systemic 
embolization in both immunocompetent and immunocompromised patients.
Mortality rate associated with endocarditis caused by NVS is 17% which is higher than that of 
viridans streptococci (0–12%) and enterococci (9%) [47].
Underlying valvular disease is commonly seen as a predisposing factor for development of 
endocarditis. Over 90% of the cases have preexisting heart disease and 10% of patients have 
prosthetic heart valves [48]. Newer data however, suggest that there is increased involvement 
of normal heart valves in the past decade [49].
Embolization is a common complication of Abiotrophia endocarditis affecting one-third of 
patients. Typical peripheral manifestations of endocarditis such as petechia, digital clubbing, 
Osler nodes are not frequently found [41].
It has been known that infective endocarditis caused by NVS carries a higher risk of emboliza-
tion, treatment failure and increased mortality as compared to infective endocarditis caused 
by viridans streptococci [4].
Stein et al. reviewed 30 published case reports of endocarditis caused by NVS and found that 
17% of patients had relapses after antibiotic therapy. Bacteriologic failure rate was 41% (defined 
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as positive blood cultures after 7 days of appropriate antibiotic therapy, relapse following a 
course of therapy with appropriate antibiotics, or a positive valve culture). It is notable that 
bacteriologic failure was seen despite the sensitivity of the organisms to the antibiotics used 
in two thirds of the cases. About 31% of the patients required surgery. Mortality rate was 17% 
which was higher than that of endocarditis caused by enterococci or viridans streptococci [41].
Similarly a more recent review of 29 cases of solely Granulicatella endocarditis by Adam et al. 
showed very high rates of complications and adverse outcomes. Incidence of heart failure 
was 30%, embolism was seen in 30% of patients and perivalvular abscess was seen in 11%. 
The mortality rate was 17%. The average vegetation size was 16 mm (31). They found that 
aortic (44%) and the mitral (38%) valves were the most commonly effected and multivalvular 
involvement was (13%) [50].
Large vegetation sizes are associated with increased risk of systemic embolism in infective 
endocarditis. Case studies reveal large vegetation sizes with infective endocarditis caused by 
NVS (greater than 10 mm in 7 out of 8 cases reviewed by Lin et al., and average vegetation size 
of 16 mm in a case series of 29 patients by Adam et al.) [50]. These findings correlate with the 
high rates of systemic embolism seen in endocarditis caused by NVS.
Endocarditis caused by NVS is associated with high rates of infectious intracranial cerebral 
aneurysms although the exact incidence is unknown. Having a low threshold for obtaining 
imaging of the CNS is reasonable even for patients with vague complaints such as severe 
localized headaches or mild confusion [3]. Many infectious intracranial cerebral aneurysms 
resolve by antibiotic treatment with reductions in size in the first 1–2 weeks. The risk of rup-
ture decreases with time on antibiotic therapy [3].
Endocarditis caused by NVS is associated with 13% of aortic valve damage and 11% of mitral 
valve damage. If not recognized on a timely basis, these patients may present with conges-
tive heart failure as the first presenting manifestation of the infection [51]. Congestive heart 
failure is a potential complication of valvular destruction which can necessitate heart valve 
replacement surgery.
Aorto-RV fistula is a rare complication of A. defectiva endocarditis that requires early surgi-
cal intervention for closure [52]. Development of hemophagocytic lymphohistiocytosis was 
reported in a previously healthy patient with A. defectiva endocarditis [53].
Endocarditis caused by NVS has rarely been reported in children. According to a review of 13 
pediatric cases in children, 69% had underlying heart disease [54]. Similar to adult patients, 
endocarditis caused by NVS in pediatric populations also appears to be associated with high 
complication rates including severe valvular damage, surgical valve replacement and sys-
temic embolization [54, 55].
6. Treatment
Antimicrobial susceptibility testing is very difficult for Abiotrophia and Granulicatella due to 
their fastidious nature. In addition, the results of susceptibility testing may not be accurate or 
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reliable. Microbiological cure is difficult and infective endocarditis caused by these organisms is 
associated with high rates of treatment failures. Therefore, AHA (American Heart Association) 
and British Society for Antimicrobial Chemotherapy (BSAC) Infective Endocarditis treatment 
guideline for Abiotrophia defectiva and Granulicatella species is very similar to treatment guide-
lines for enterococcal endocarditis [33, 56].
Recommended treatment regimen is Ampicillin (12 g/d in divided doses) or penicillin (18–30 
million U/D in divided doses or by continuous infusion) plus gentamicin 3 mg/kg/d in 2–3 
divided doses).
For those patients who are intolerant to penicillin, Vancomycin alone without the use of gen-
tamicin can be given for therapy. This is in contrast to enterococcal endocarditis treatment 
where Vancomycin is combined with gentamicin [33].
The duration of treatment for Abiotrophia or Granulicatella endocarditis needs to be determined 
by consultation with an infectious disease expert. As a general guidance, AHA recommenda-
tions for treatment durations for enterococcal endocarditis are as follows:
The treatment duration is 4 weeks for native valve endocarditis with symptoms or illness 
≤3 months. 6 week therapy is recommended for patients with symptoms >3 months. For pros-
thetic valve or other prosthetic cardiac material infections, minimum 6 weeks of antibiotic 
therapy is recommended [33].
Historically, in animal models it was shown that Penicillin alone was inferior to Penicillin plus 
aminoglycoside or Vancomycin alone for the treatment of infective endocarditis caused by NVS 
[57, 58]. it was shown that penicillin plus low dose (0.32 mg/kg) vs. high dose (1.05 mg/kg) gen-
tamicin treatment results were virtually identical [57].
There is encouraging data to suggest that shortened courses of aminoglycosides in the treat-
ment regimens (median 15 days) may result is similar clinical outcomes in treatment of 
enterococcal endocarditis. However this particular issue requires further study and it is not 
yet known how this would apply to treatment of infective endocarditis caused by Abiotrophia 
defectiva or Granulicatella species. [49].
Given the growing concerns over antibiotic resistance among NVS, poor treatment outcomes 
and high rates of treatment failures it is important to look into data for susceptibilities of a broad 
range of antibiotics. There is however limited data available regarding the antibiotic suscepti-
bilities of Granulicatella and Abiotrophias spp. due to the rare nature of the infections, the specific 
nutritional growth requirements and difficulties in standardization of testing methodologies.
7. Penicillin
NVS have the highest in vitro penicillin resistance compared to any other streptococci. The 
rate of penicillin resistance among NVS appears to be rising over the years. While an ear-
lier study by Cooksey and Swenson in 1979 [59] and Gephart and Washington in 1982 [60] 
showed no isolates had a penicillin MIC >1 μg/ml, subsequent studies showed significantly 
increasing penicillin resistance; Bosley and Facklam in 1990 [61] noted 9% rate of resistance 
Endocarditis Caused by Abiotrophia and Granulicatella Species
http://dx.doi.org/10.5772/intechopen.74252
47
to penicillin and Alberti in 2016 [62] reported 14% rate of penicillin resistance among NVS. It 
is also notable that the method of penicillin susceptibility testing has changed over the years. 
Douglas et al. (1994) [63] found that while historical method of penicillin susceptibility testing 
by reference dilution method did not find penicillin resistance, when same NVS isolates were 
tested with E test, 7% penicillin resistance was detected. The high rate of penicillin resistance 
among VNS appears also to be consistent among NVS isolates from pediatric infections [64].
According to antibiotic susceptibility testing of 132 isolates by Albierti et al. in 2016, only 
33% of the 132 isolates were susceptible to penicillin and 14% were resistant with an MIC 
≥4 μg/ml. The remaining 53% of the isolates had penicillin MICs in the intermediate category 
(0.25–2 μg/ml) [62]. Liao et al. reported 50% of their isolates (14 out of 28 isolates) had inter-
mediate susceptibility to penicillin [65].
There appears to be differences in penicillin susceptibilities among different species of 
NVS. Albierti et al. showed that penicillin susceptibility is much less among A. defectiva com-
pared to G. adiacens (10.8% vs. 38.9%). G. elegans isolates are highly susceptible to penicillin 
with MIC of 0.03 μg/ml (n = 5) [62].
In an earlier study by Touhy et al. in a review of 39 isolates from 1995 to 1999, similar to 
Albierti et al.’s findings, G. adiacens penicillin sensitivity was higher than that of A. defectiva; 
55 vs. 8% respectively. [66].
7.1. Penicillin tolerance
It is notable that clinical failures of treatment have frequently been described even for peni-
cillin susceptible strains when appropriate antibiotics are given. Holloway et al. described a 
phenomenon of penicillin tolerance among NVS which minimum bactericidal concentration 
(MBC) significantly exceeded (greater than 32) the minimum inhibitory concentration (MIC) 
that would lead to a slower antibiotic effect and potentially a worse clinical response. In addi-
tion to the usual nutritional supplements of vitamin B6 and cysteine to the plates, by add-
ing penicillinase to the subculture medium and a staphylococcal streak across the plates they 
showed that even though all tested isolates were susceptible to penicillin (MICs of the strains 
ranged from 0.05 to 0.4 U of penicillin per ml), 100% of the isolates were penicillin tolerant. The 
isolates did not show any penicillin tolerance if the subculture was supplemented only with 
pyridoxal and cysteine [67]. Therefore, in order to identify penicillin tolerance and not mis-
identify the strains as penicillin sensitive, it is necessary to add penicillinase to the medium in 
addition to the usual growth supplements, pyridoxal HCl, cysteine and staphylococcal streak.
The slow growth rate of NVS is also thought to be responsible from poor response to antibi-
otic treatment. NVS generation time is 2–3 h while viridans streptococci generation time is 
40–50 min [2, 41, 68].
7.2. Susceptibility testing
According to the latest consensus guidelines from the Clinical and Laboratory Standards 
Institute (CLSI) for antimicrobial susceptibility testing for infrequently isolated or fastidious 
bacteria, disk diffusion test for Abiotrophia and Granulicatella species is not recommended. 
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Instead, broth microdilution MIC testing by laboratories experienced in such testing is recom-
mended. CLSI suggests broth microdilution MIC testing in Cation adjusted Mueller-Hinton 
broth with 2.5–5% lysed horse blood and 0.001% pyridoxal HCl [69].
E test is proven to be a rapid and simple method for MIC estimation for NVS, comparable to 
broth microdilution MIC testing [63].
CLSI consensus guidelines also emphasize that cases of Abiotrophia or Granulicatella infec-
tions can be managed by following the treatment recommendations in the medical literature 
without antimicrobial susceptibility testing. The antimicrobial susceptibility testing can be 
reserved for those cases where there is persistent infection, clinical failure, allergy or intol-
erance to the drugs of choice and possible resistance to the drugs that might be prescribed. 
Infectious disease specialists or other expert clinicians should make all susceptibility testing 
decision and test interpretation [69].
7.3. Cephalosporins
Penicillin resistance is often associated with resistance or decreased susceptibility to other 
beta-lactam antibiotics including ceftriaxone [66].
However, overall cephalosporin susceptibility among NVS appears to be higher compared 
to penicillin. In addition, A. defectiva appears to have higher susceptibility to 3rd generation 
cephalosporins compared to G. adiacens. According to a large review of susceptibilities of 
antibiotic susceptibility testing for 132 clinical NVS isolates from blood cultures that were 
isolated from 2008 to 2014 at Los Angeles hospitals by Albierti et al., Ceftriaxone susceptibil-
ity was 61.4% and Cefotaxime susceptibility was 43.2% among all isolates. A. defectiva was 
more susceptible than G. adiacens to the third generation cephalosporins (94.6% vs. 18.9% for 
Cefotaxime and 100% vs. 43.3% for ceftriaxone). Ceftriaxone susceptibility breakpoint was 
MIC ≤1 μg/ml as per CLSI M45 [62, 69]. Touhy et al. had found a similar susceptibility pattern 
of susceptibility for ceftriaxone; they had observed that 83% of the A. defectiva isolates and 
63% of G. adiacens isolates were susceptible to Ceftriaxone by using MIC ≤0.5 susceptibility 
breakpoint [66]. Zheng et al. reported that out of 15 isolates of Abiotrophia and Granulicatella, 
9 were resistant to Ceftriaxone (MIC of >2 μg/ml), 13 were resistant to Cefuroxime (MIC of 
>2 μg/ml) [64]. All six isolates of G. adiacens in their review were resistant to Ceftriaxone [64].
Albierti et al. noted that some of the isolates that were resistant to ceftriaxone still remained 
susceptible to Ceftaroline. (51.6% of G. adiacens isolates resistant to ceftriaxone with an MIC 
≥4 μg/ml had Ceftaroline MICs of ≤1 μg/ml). On the other hand, 32% of G. adiacens isolates 
that were resistant to ceftriaxone (MIC ≥4) had Ceftaroline MICs ≥4 μg/ml. These isolates were 
noted to be resistant to penicillin (MIC ≥4 μg/ml). The Ceftaroline MIC90 for all isolates were 
lower compared to Cefotaxime or Ceftriaxone (2 versus >4 μg/ml) [62].
Resistance to higher generations of cephalosporins have been reported such as Cefepime 
(2 out of 21 isolates) [70] and Cefotaxime (7 out of 28 isolates were resistant) [65].
Species related differences of penicillin or cephalosporin sensitivities in determining anti-
biotic choices remains to be investigated. The high rates of ceftriaxone resistance among 
G. adiacens isolates appear to be fairly consistent across various studies.
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European Society of Cardiology (ESC) Clinical Practice Guidelines include Ceftriaxone in 
their recommendations for treatment of endocarditis caused by A. defectiva or Granulicatella 
slightly differing from AHA recommendations. ESC recommendation for treatment of IE 
caused by A. defectiva or Granulicatella is Penicillin G, Ceftriaxone or Vancomycin for 6 weeks, 
combined with an aminoglycoside at least for the first 2 weeks [71].
8. Vancomycin
Iv Vancomycin is recommended as an alternative regimen to iv penicillin for those patients 
who are not able to tolerate penicillin or ampicillin [33].
Bouvet et al. by using an experimental animal model found that Vancomycin alone was as good 
as combination of Vancomycin and Gentamicin for treatment of endocarditis caused by NVS [58].
Vancomycin susceptibility breakpoint is typically MIC <1 μg/ml and no resistance to Vancomycin 
among NVS has been reported thus far [62, 64, 66]. It is notable however that MIC90 for 
Vancomycin is 2 times higher for G. adiacens compared to A. defectiva or G. elegans [62, 66].
9. Aminoglycosides
NVS remains susceptible to aminoglycosides (MICs for Gentamicin and streptomycin 
≤4 μg/ml), high level aminoglycoside resistance has not been reported. As per AHA and 
BSAC guidelines for treatment of infective endocarditis caused by Abiotrophia or Granulicatella 
species, iv gentamicin is combined with iv penicillin (first line treatment) [33, 56].
10. Macrolides
Macrolide resistance is common among Abiotrophia and Granulicatella species (49.2% of all isolates 
sensitive to erythromycin vs. 87% of all isolates sensitive to Clindamycin) [62]. Resistance mecha-
nisms include efflux among mef(A) positive isolates and erm(B) gene causing resistance to both 
Erythomycin and Clindamycin [64]. It was shown that erm(B) gene is located on Tn916-related 
transposon in A. defectiva similar to the pneumococcal transposon Tn3872, enabling Abiotrophia 
to act as a donor and recipient of antibiotic resistance [72]. Macrolide resistance pattern of NVS 
is suggestive of constitutive macrolide-lincosamide-streptogramin B (cMLSB) phenotype. Zheng 
et al. noted that all three isolates of NVS that carried erm(B) (G. adiacens and G. elegans) also carried 
tet(M), tetracycline resistance gene which is carried on the same transposon as ermB gene [62, 64].
11. Carbapenems
Resistance to Meropenem or Imipenem among Abiotrophia and Granulicatella species is rare. 
Review of 132 isolates by Albierti showed 100% sensitivity to Meropenem and Imipenem 
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(MIC ≤0.06 μg/ml for both antibiotics) [62]. Touhy et al. [66] found that 3 isolates of A. adiacens 
(out of 27 total isolates) and 7 isolates of G. defectiva (out of 12 total isolates) had increased 
MICs of Meropenem (0.5 μg/ml). These isolates also had penicillin MICs ≥0.5 μg/ml. One 
of their isolates of A. adiacens had a high MIC for Meropenem (MIC of 1 μg/ml) which was 
isolated from a patient with suspected intervertebral disc space infection who had received 
a prolonged course of various antibiotics including beta-lactams. This particular isolate was 
also resistant to penicillin and ceftriaxone (MICs ≥8 μg/ml).
12. Quinolones
Resistance to quinolones among NVS is rare. 8 G. adiacens [62] and one G. elegans [70] iso-
lates have been reported to be resistant to Levafloxacin. The case of G. elegans resistant to 
Levafloxacin was isolated from a patient with neutropenic fever with bacteremia who had 
previously received Levafloxacin therapy. Mechanism of NVS resistance to quinolones is yet 
to be determined [62].
13. Daptomycin and linezolid
There are no CLSI defined sensitivity breakpoints for Daptomycin and Linezolid 
for NVS. Albierti et al. found that Daptomycin MICs appear to be relatively high for 
NVS. Daptomycin MIC90 was >4 μg/ml for A. defectiva, 4 μg/ml for G adiacens and 0.5 μg/ml 
for G. elegans. According to the CLSI breakpoint of susceptibility for viridans group 
Streptococci is MIC ≤1 μg/ml, majority of the tested isolates (89.4%) would be considered 
resistant to Daptomycin [62, 69]. The reason for relatively high Daptomycin MICs for 
A. defectiva and G. adiacens is not clear. This may be due to an inherent resistance of these 
bacteria to Daptomycin potentially due to differences in cell wall composition [62]. In a 
prior study a smaller number of NVS isolates (n = 10) were found to have MICs ≤0.125–2 
[73]. The reason for the discrepancy in the findings of these two studies is not known and 
merits further investigation.
When the breakpoint of Linezolid susceptibility for viridans group streptococci (MIC ≤2 μg/ml) 
is applied to NVS, all NVS would be considered susceptible to Linezolid according to one study 
of 132 isolates [62, 69]. It was noted that G. adiacens MIC90 for Linezolid is higher (2 μg/ml) 
than that of A. defectiva and G. elegans (1 μg/ml) [62].
14. Rifampin
Rifampin appears to be one of the most effective antibiotics against NVS although the data is 
limited. It was shown that Rifampin had a minimal bactericidal concentration of 2 μg/ml while 
that of penicillin was 1 μg/ml [60]. Combination of Vancomycin and Rifampin showed synergy 
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in in vitro studies [74]. According to one review of 15 isolates of Abiotrophia and Granulicatella 
species, all isolates were found to be susceptible to Rifampin with MICs ≤0.012 μg/ml [64].
15. Role of surgery
Endocarditis caused by NVS is associated with high rates of complications including heart 
failure, embolization and valvular damage. The need for surgery and time of surgery remains 
to be determined. However based on outcomes of several cases published in the literature, the 
rate of surgical treatment is very high especially due to development of heart failure.
he rate of valve surgery is high; 51% (in a review of 29 cases of Granulicatella endocarditis by 
Adam et al.) [50], 48% (review of 23 cases of endocarditis caused by NVS by Guiliano et al.) 
[49], 38% (review of 30 cases of endocarditis caused by NVS by Stein et al.) [41], 44% (review 
of 9 cases of A. defectiva endocarditis by Hashimoto et al.) [75].
A vegetation size of 10 mm or more is associated with increased mortality and increased 
risk of embolic events [76]. EASE Trial showed that early surgery in infective endocarditis in 
patients with large vegetations significantly reduced the mortality, risk of systemic embolism 
or recurrence of infective endocarditis (3% in the early surgery group vs. 28% in the conven-
tional treatment group) [77]. Lin et al. [68] reported 7 out of 8 cases of endocarditis caused by 
NVS had large vegetation sizes (10 mm). In the same review, 7 out of 8 cases required surgery 
(4 out of 8 cases required early valve replacement due to severe heart failure, while 3 cases 
underwent mitral valve repair 2,4, and 7 months after the diagnosis of endocarditis).
Combined approach with antibiotic treatment and surgery provides the best outcomes in 
endocarditis caused by NVS. Specifically, early surgical intervention should be considered for 
those patients with heart failure due to valvular destruction [68], hemodynamic compromise 
[49] or large vegetation sizes [68, 77].
16. Conclusion
Infective endocarditis caused by NVS has posed tremendous diagnostic and therapeutic chal-
lenges and continue to do so even in the era of modern medicine. Delays in diagnosis due to 
difficulties in identification frequently cause delays in treatment and poor treatment outcomes. 
Treatment failure and high complication rates associated with Abiotrophia and Granulicatella 
endocarditis is at least partially attributable to the pleomorphic nature of the organisms, lack 
of growth in subcultures and specific nutritional requirements in media along with the need 
for the microbiology lab staff to have heightened awareness of these microorganisms. Their 
fastidious nature of NVS makes the antibiotic susceptibility testing fairly difficult, causing 
delays in initiation of timely and effective antibiotic treatment.
Interpretation of the medical literature of Abiotrophia and Granulicatella spp. and its applica-
tion to current clinical practice is challenging as the names of these organisms have been 
changed several times and not uncommonly the two genera were addressed together. There is 
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lack of large clinical studies and our knowledge about these organisms is based on relatively 
small number of reported cases.
Differences in pathogenicity and susceptibility to antimicrobials have been demonstrated 
among these heterogeneous group of bacteria. More studies are needed to determine if there 
are further species specific differences of these fascinating microorganisms which would help 
us improve our understanding, diagnosis and the treatment outcomes of infections caused 
by NVS.
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